RE:RE:RE:RE:NowBoudi,
I'm now with you. I want FDA correspondence to Therma Bright to be open to shareholders to know exactly what they have asked for. No different from minining company disclosure and applications. As shareholders, FDA requests are material and should be shared with all investors in this case so we all have insight into the challenges at hand. FDA requests are material and should be disclosed to the public market. PERIOD. FIA needs to provide detail ASAP on time to respond and specifically what they need to respond to. The NR today was BS. Inbox me. i'll go the distance on this one. I have asked these questions of Rob today and all i got was, "per the NR, we cannot provide timelines for FDA review/approval" my response to Rob, was...."I get that Rob, but can you provide timelines on when you can respond to their questions and whether there is the need for another clinical trial" Another clinical trial, if required, is material news and should be disclosed ASAP. Rob failed to disclose this really. Detail required. More detail, otherwise, i'm ok to put him into big trouble myself. Another Clinical trial is very material and should be disclosed to the market and all investors. The NR today was BS. With you.